Aspergillus species are the most frequent cause of fungal infections of the lungs with a
broad spectrum of clinical presentations including invasive pulmonary aspergillosis (IPA) …

The airborne fungus Aspergillus fumigatus poses a serious health threat to humans by
causing numerous invasive infections and a notable mortality in humans, especially in …

Invasive aspergillosis (IA) in haematology/oncology patients presents as primary infection or
breakthrough infection, which can become refractory to antifungal treatment and has a high …

Invasive pulmonary aspergillosis (IPA) remains difficult to diagnose and to treat. Most
common risk factors are prolonged neutropenia, hematopoietic stem cell or solid organ …

Introduction Fungal PCR has undergone considerable standardization and, together with
the availability of commercial assays, external quality assessment schemes, and extensive …

Invasive mold infections (IMIs) are associated with high morbidity, particularly in
immunocompromised patients, with mortality rates between 40% and 80%. Early initiation of …

Abstract Information on invasive aspergillosis (IA) and other invasive filamentous fungal
infections is limited in non-neutropenic patients admitted to the intensive care unit (ICU) and …

Invasive pulmonary aspergillosis (IPA) is a serious condition resulting in significant mortality
and morbidity among patients in intensive care units (ICUs). There is a growing number of at …

Coronavirus disease 2019 (COVID-19) infection is currently a great cause of concern for the
healthcare sector around the globe. SARS-CoV-2 is an RNA virus that causes a serious …

Invasive pulmonary aspergillosis (IPA) is a life-threatening disease that affects mainly
immunocompromised hosts. Galactomannan testing from serum and bronchoalveolar …